Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC3046 Ldd970
Novel Aurora Kinase A Inhibitor
More description
DCC3045 Ldd-1819
Novel dual inhibitor of GSK-3β and aurora kinase A, increasing somatic cell plasticity and inhibiting tumorigenicity
More description
DCC3044 Ldc8201
Novel potent and selective covalent inhibitor of EGFR and Her2 exon20 insertion mutations, exhibiting selectivity over wild type EGFR and within the kinome
More description
DCC3043 Ldc7559
Novel potent inhibitor of the NOX2-dependent oxidative burst in neutrophils by activating the glycolytic enzyme phosphofructokinase-1 liver type (PFKL) and dampening flux through the pentose phosphate pathway
More description
DCC3042 Ldc0496
Novel potent and selective covalent inhibitor of EGFR and Her2 exon20 insertion mutations, exhibiting selectivity over wild type EGFR and within the kinome
More description
DCC3041 Lcrf-0004
Novel potent and selective RON receptor tyrosine kinase inhibitor
More description
DCC3040 Lcl-peg3-n3
Novel clickable linker for estrogen receptor degraders
More description
DCC3039 Lcb03-0110
Novel potent angiogenesis inhibitor, inhibiting VEGFR-2 and JAK/STAT3 signalling in primary cultured human endothelial cells and cancer cells
More description
DCC3038 Lcat Activator A
Novel activator of Lecithin:cholesterol acyltransferase (LCAT) including some familial mutations, by forming a hydrophobic adduct with Cys31
More description
DCC3037 Lc0024
Novel antibiofilm coating, covalently bindng to a titanium implant surface (LC0024-Ti)
More description
DCC3036 L-bmaa Hydrochloride
Neurotoxic amino acid
More description
DCC3035 Lb30889
Prodrug of LB30870 as potent, orally active, selective and direct thrombin inhibitor
More description
DCC3034 Lb30870
Potent, orally active, selective and direct thrombin inhibitor
More description
DCC3033 Laxaphycin B
Natural inhibitor of the proliferation of sensitive and resistant human cancer cell lines and this inhibitory activity is strongly increased in the presence of laxaphycin A
More description
DCC3032 Laxaphycin A
Natural antifungal and cytotoxic agent
More description
DCC3031 Laulimalide
Microtubule stabilzer, potently inhibiting cellular proliferation in cancer cell lines
More description
DCC3030 Latrunculin A
Disruptor of microfilament-mediated processes
More description
DCC3029 Latonduine B
Natural F508del-CFTR trafficking corrector, targeting poly(ADP-ribose) polymerase (PARP)
More description
DCC3028 Latonduine A
Natural F508del-CFTR corrector, inhibiting both PARP-3 and -16, regulating the activity of the unfolded protein response activator inositol-requiring enzyme (IRE-1) via modulation of the level of its ribosylation by PARP-16
More description
DCC3027 Lassbio-1911
Novel Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitor
More description
DCC3026 Lassbio-1829 Hydrochloride
Novel orally active IKK2 inhibitor
More description
DCC3025 Lassbio-1524
Novel IKK-β inhibitor, reducing the secretion of TNF-α, IL-1β, IL-6, IL-12, IFN-γ and increased secretion of IL-10, protecting gastrointestinal homeostasis
More description
DCC3024 Lassbio-1366
Novel Adenosine A2a Receptor Agonist, Attenuating the Progression of Monocrotaline-induced Pulmonary Hypertension
More description
DCC3023 Lassbio-1359
Novel adenosine receptor agonist, inducing relaxation of corpus cavernosum; Novel selective phosphodiesterase-​4 (PDE4) inhibitor associated with anti-​TNF-​α properties
More description
DCC3022 Lassbio-1135
Novel dual TRPV1 antagonist and TNF-alpha production inhibitor
More description
DCC3021 Laspartomycin C
Lipopeptide antibiotic with activity against a range of Gram-positive bacteria including drug-resistant pathogens
More description
DCC3020 Lasiojasmonate A
Natural fungal phytotoxin, activating the plant jasmonic acid pathway
More description
DCC3019 Las191859
Novel, potent and selective CRTh2 antagonist
More description
DCC3018 Largazole
Potent inhibitor of histone deacetylase
More description
DCC3017 laquinimod Sodium
Novel Modulator of autoimmune demyelination
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X